Awareness : Newsletter Articles

Bendamustine Hydrochloride (Treanda®, Bendeka™)-Revision to Part A and Part B LCD

LCD ID number: L33268 Effective for services rendered on or after July 06, 2017, the local coverage determination (LCD) for bendamustine hydrochloride (Treanda®, Bendeka™) was revised to add the indication “Non-Hodgkin’s Lymphoma (NHL) - Adult T-cell Leukemia/Lymphoma” to the “Indications and Limitations of Coverage and/or Medical Necessity” section of the LCD under “off-labeled indications”. Also, the ICD-10-CM codes C91.50 and C91.52 were added to the “ICD-10 Codes that Support Medical Necessity” section of the LCD for Healthcare Common Procedure Coding System (HCPCS) codes J9033 and J9034.